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Abstract
BACKGROUND: Ionizing radiation is a strong stimulator of reactive oxygen specises (ROS) and reactive nitrogen species 
(RNS). These reactive species may cause oxidative and nitrosative stress. In this study, we aimed to evaluate possible effects of 
99mTechnetium (99mTc)-methoxyisobuthylisonitrite (MIBI), 99mTc-dimercaptosuccinic acid (DMSA), 99mTc-mercaptoacetyltriglycine 
(MAG-3) on oxidative and nitrosative stress biomarkers in patients who were performed myocardial perfusion scintigraphy 
(MPS) and renal scintigraphy.
MATERIAL AND METHODS: Patients (n = 29) who were referred to nuclear medicine department were chosen as the patient 
group. They were divided into three subgroups according to the type of disease and 99mTc labelled agent. The first patient 
group had MPS (n = 9). The second patient group had 99mTc-DMSA renal scintigraphy (n = 12). The third patient group had 
99mTc-MAG-3 renal scintigraphy (n = 8). The blood samples were taken from first, second and third patient groups 1 h, 3 h, 
45 min after injection of the agent, respectively. The samples were taken from healthy volunteers (n = 25) as a control group. 
Alterations in catalase (CAT),superoxide dismutase (SOD), malondialdehyde (MDA) levels as oxidative stress biomarkers and 
nitric oxide (NO) and 3-Nitrotyrosine (3-NTx) levels as nitrosative stress biomarkers in all blood samples were evaluated.
RESULTS: Results of MPS and renal scintigraphy performed patients were compared with control group separately. CAT, SOD, 
MDA and 3-NTx levels were higher in the first group than the control group (p < 0.05). Although NO levels were higher in the 
first group than the control group, it was not statistically significant (p > 0.05). CAT and SOD levels were lower in second and 
third groups than the control group (p < 0.0 5). However, MDA, NO, 3-NTx levels were higher in second and third groups than 
the control group (p < 0.05). 
CONCLUSIONS: These results show that oxidative and nitrosative balance is impaired due to ionization radiation. These reac-
tive species might stimulate an adaptive and protective cellular defense mechanism in irradiated cells soon after exposure to 
radiation. Thereby, this mechanism protect organism from the effects of low dose ionizing radiation.
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Introduction
99mTechnetium (99mTc) and 99mTc-labeled radiopharmaceu-
ticals widely are used more than 50 years in clinical nuclear 
medicine applications. 99mTc has both 140 keV gamma emission 
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and approximately 5 low energy Auger and internal conversion 
electrons per decay. 99mTc’s half-life (t1/2) is six hours. 99mTc-meth-
oxyisobuthylisonitrite (MIBI) is used for myocardial perfusion scintig-
raphy (MPS) [1, 2]. 99mTc-dimercaptosuccinic acid (DMSA) is used 
for renal cortical scintigraphy and 99mTc-mercaptoacetyltriglycine 
(MAG-3) is used for dynamic renal scintigraphy [3]. Although the 
importance of 99mTc has been accepted in the worldwide, it re-
sults high ionization radiation intensity near the radionuclide’s decay 
position due to emitted beams [2]. After intravenous (i.v.) injection 
of the radiopharmaceutical, it distributes into living cells and ion-
izing radiation is absorbed by these living cells. Cellular exposure 
to ionizing radiation initiates oxidizing process. This process dam-
ages cells and their structures at the atomic level via direct inter-
actions with macromolecules such as DNA, RNA, proteins and 
lipids or radiolysis of water. Furthermore, this damage might spread 
to neighbour cells via bystander effect and persist in the progeny 
for many generations [4–7]. 
During the radiolysis of water-reactive oxygen species (ROS) 
including superoxide anion, hydrated electron, hydroxyl radical, 
hydrogen peroxide, organic hydroperoxides, alkoxy and peroxy 
radicals, hypochlorite, peroxynitrite are produced. Ionizing radia-
tion also causes the production of reactive nitrogen species (RNS). 
As a result of that, large amounts of nitric oxide and peroxynitrite 
anion are produced [7, 8].
ROS/RNS initiate harmful process in cells. Different signalling 
cascades adaptive responses including DNA repair, antioxida-
tion reactions and different signalling cascades are stimulated to 
overcome these harmful process. Ionizing radiation regulates an-
tioxidant enzyme activity depending on dose and linear energy 
transfer. While a low dose of LET radiation (gamma rays) at low 
dose-rate stimulates antioxidant defense system, high LET radia-
tion spreads oxidative stress both in the irradiated cells and nearby 
cells by means of bystander effect [7]. Antioxidants defense sys-
tems play a crucial role for preventing damage caused by ROS/RNS 
and eliminating ROS/RNS The imbalance in the production and 
the elimination of ROS/RNS and various reducing or antioxidant 
systems of the body causes oxidative/nitrosative stress [7, 9, 10].
To our knowledge, this is the first study in the current litera-
ture that investigates the effects of 99mTc-MIBI, 99mTc-DMSA and 
99mTc-MAG-3 oxidative/nitrosative damage in human. The present 
study was aimed to evaluate levels of both oxidative stress biomark-
ers including catalase (CAT), superoxide dismutase (SOD), malon-
dialdehyde (MDA) and nitrosative stress biomarkers including nitric 
oxide (NO) and 3-Nitrotyrosine (3-NTx) in patients who were clini-
cally indicated and underwent 99mTc-MIBI MPS, 99mTc-DMSA renal 
cortical scintigraphy and 99mTc-MAG-3 dynamic renal scintigraphy.
Material and methods
Ethics
This study was conducted after obtaining approval from the 
local ethical committee of Sutcu Imam University, Medical Faculty, 
Kahramanmaras, Turkey. Also, the study was conducted in accord-
ance with the Declaration of Helsinki on medical protocols and 
ethics. As we used routinely generated data with no identifying infor-
mation, the study carries no harm whatsoever to patients. Data were 
used only for scientific purposes. All participants were informed 
extensively about this study and signed an informed-consent form 
before they were enrolled in this study. 
Study population
A total of 29 patients who were referred to the nuclear medi-
cine department and who were routine scintigraphic imaging 
methods were indicated were chosen as the patient group. The 
patients were divided into three subgroups based on the type 
of disease and 99mTc labelled agent. The 99mTc labelled imaging 
agents were administered at clinical doses.
In 9 patients (2 female, 7 male) with a mean age of 52 ± 9.7 
years (range 38-67 years), MPS with 99mTc-MIBI was obtained 
(group 1).
In 12 patients (8 female, 4 male) with a mean age of 20 ± 21.6 
years (range 1-66 years), renal cortical scintigraphy with 99mTc-DMSA 
was carried out (group 2).
In 8 patients (6 female, 2 male) with a mean age of 28 ± 21.4 
years (range 6 and 66 years ) dynamic renal scintigraphy with 
99mTc-MAG-3 was performed (group 3).
The blood samples were taken from first group 1h after intra-
venous (i.v.) injection of 99mTc-MIBI, from second group 3h after i.v. 
injection of 99mTc-DMSA, from third group 45min, after i.v. injec-
tion of 99mTc-MAG-3. The samples were also taken from a total of 
25 healthy volunteers with a mean age of 39 ± 13.1 years (range 
18–63 years) as a control group. 
Alterations in both CAT, SOD, MDA levels as oxidative stress bio-
markers and NO and 3-NTx levels as nitrosative stress biomarkers in 
all blood samples were evaluated.
Biochemical analysis in erythrocytes
The blood samples were centrifuged at 3000 g for 10 minutes at 
4ºC. Plasma was separated and the buffy coat was discarded by 
aspiration. Erythrocytes were washed 4 times with cold physiologi-
cal saline and stored at −70°C until analysis. The CAT activity in 
erythrocyte was measured in samples by the method applied by 
Beutler [11]. The decomposition of the substrate H2O2 was moni-
tored spectrophotometrically at 240 nm. The activity of CAT was ex-
pressed as U/g Hb. The SOD activities in erythrocyte were estimated 
by the use of the method described by Fridovich [12]. SOD activity 
was expressed as U/g Hb. Lipid peroxidation level in the plasma 
samples was expressed in MDA. Measurement was based on the 
method of Ohkawa [13]. MDA levels were expressed as nmol/mL. 
NO and 3-NTx levels in plasma samples were determined with 
a “sandwich” enzyme-linked immunosorbent assay kits (mybio-
source human elisa kits, USA) according to the manufacturers’ 
protocol. Then, 3-NTx levels were given as nmol/L.
Statistical analysis
Data were analyzed using the statistical package SPSS for 
Windows version 20.0 (SPSS Inc., Chicago, IL.). Results were 
expressed as mean±SD. The conformability of the quantitative 
data to the normal distribution was examined by the Kolmogo-
rov–Smirnov test. The Mann–Whitney U-test was used to compare 
mean values for all parameters between patients and control 
groups. p value < 0.05 was accepted as statistically significant.
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Results
Results of MPS and renal scintigraphy performed patients were 
compared with control group separately. 
Initially, MPS performed patients group were evaluated. The 
antioxidant enzyme activities of CAT and SOD were statistically 
significantly higher in the first patient group than the control group 
(p < 0.05) as shown in Figure 1A and 1B. CAT and SOD levels were 
approximately 1.9 and 1.7 fold higher in the first patient group than 
healthy subjects, respectively. In addition, MDA levels were also 
statistically significantly higher in the first patient group than the 
control group (p < 0.05) and its levels were nearly 1.6 fold higher 
in the first patient group as shown in Figure1C. 3-NTx levels were 
statistically significantly nearly 1.8 fold higher in the first patient 
group than control group (p < 0.05) as shown in Figure 2B. NO 
levels were nearly 1.2 fold higher in the first patient group than 
control group (p > 0.05) as shown in Figure 2A.
Then, renal scintigraphy performed patients group were evalu-
ated. CAT and SOD levels were statistically significantly lower in 
second, third and total renal scintigraphy performed patient 
groups than control group (p < 0.05). CAT and SOD levels were 
nearly 2 and 3 fold lower in the second patient group than control 
group, respectively (Fig. 3A and 3B). CAT and SOD levels were 
nearly 1.7 and 3 fold lower in the third patient group than control 
group, respectively (Fig. 5A and 5B). CAT and SOD levels were 
nearly 2 and 3 fold lower in total renal scintigraphy performed 
patients group than control group, respectively (Fig. 7A and 7B). 
MDA levels were statistically significantly higher in second, third and 
total renal scintigraphy performed patient groups than the control 
group (p < 0.05). MDA levels were nearly 2, 2 and 1.8 fold higher 
in second, third and total renal scintigraphy performed patient 
groups than the control group, respectively (Fig. 3C, 5C and 7C). 
NO levels were nearly 1.5, 2 and 1.6 fold higher in second, third 
and total renal scintigraphy performed patient groups than the 
control group, respectively (p < 0.05) (Fig. 4A, 6A and 8A). 3-NTx 
levels were nearly 2.3, 2.85 and 2.6 fold higher in second, third and 
total renal scintigraphy performed patient groups than the control 
group, respectively (p < 0.05) (Fig. 4B, 6B and 8B).
Discussion
In this study, we investigated the effect of ionizing radiation on 
both oxidative and nitrosative stress parameters in patients who 
were clinically indicated 99mTc-MIBI MPS, 99mTc-DMSA renal cortical 
scintigraphy, 99mTc-MAG-3 dynamic renal scintigraphy. This is the 
first study that evaluates levels of nitrosative stress parameters in 
patients with these scintigraphic imaging agents.
99mTc-MIBI is a lipophilic cationic complex, enters cells by 
passive diffusion. It is localized mostly in the mitochondria of 
myocytes due to negative mitochondrial membrane potential [1, 
2, 15]. 99mTc-DMSA is a renal cortical agent that primarily bound in 
the proximal tubule in the renal cortex for a prolonged time after 
injection. 99mTc-MAG-3 is commonly used renal tubular agent in 
nuclear medicine practice [3]. It is known that the DNA-binding 
traits of 99mTc labelled agents augmentes radiotoxicity of these 
agents [1, 2, 14–16]. 
CAT, SOD, MDA, 3-NTx levels were found statistically significant-
ly higher in MPS performed patients than control group (p < 0.05) 
and 1.9, 1.7, 1.6, 1,8 fold higher in patients, respectively. NO lev-
els were 1.2 fold higher in patients than control group (p > 0.05). 
The results of this study showed that antioxidant enzyme activi-
ties of CAT and SOD levels were significantly higher in 99mTc-MIBI 
administered group than the control group (p < 0.05). Because 
shortly after exposure to 99mTc-MIBI, cellular protective pathways are 
triggered to overcome radiation-induced ROS. In addition, we 
Figure 1. The activities of catalase (CAT); A. Superoxide dismutase 
(SOD); B. and malondialdehyde (MDA); C. Levels as oxidative stress 
biomarkers in first patient group and control group
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Figure 2. The activities of nitric oxide (NO); A. and nitrotyrosine 
(3-NTx); B. Levels as nitrosative stress biomarkers in first patient group 
and control group
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Figure 3. The activities of catalase (CAT); A. Superoxide dismutase 
(SOD); B. and malondialdehyde (MDA); C. Levels as oxidative stress 
biomarkers in second patient group and control group
A 
 
B 
 
C 
 
0
5
10
15
20
DMSA Control
CAT 
0
500
1000
1500
2000
2500
3000
3500
4000
DMSA Control
SOD 
0
1
2
3
4
5
6
DMSA Control
MDA 
previously reported same results in patients have thyroid and bone 
scintigraphy [17, 18]. However, 99mTc-MIBI caused decreased SOD 
levels in mice [19].
In contrast to MIBI administered group, CAT and SOD levels were 
significantly lower in 99mTc-DMSA, 99mTc-MAG-3 administered pa-
tients and total renal scintigraphy performed patients than control 
group in this study (p < 0.05). 99mTc-DMSA stays in the proximal tubule 
in the renal cortex for a prolonged time after injection. 99mTc-MAG-3 
is a renal tubular agent. Renal imaging agents might induce free 
radical production more than MPS imaging agent. In addition, renal 
diseases cause oxidative stress. Therefore, antioxidant enzyme 
levels decreased in this group of patients. It has also been reported 
in the literature that exposure to radiation due to different radiop-
harmaceuticals including 99mTc-diethylene trimine pentaaceticacid 
(DTPA) [20], 99mTc-MIBI, 201Thallium, 99mTc-MIBI, 99mTc-methylendip-
hosphonate (MDP) [19, 21–23] and 2.45 GHz microwave radiation 
[24] caused same results in animal and human studies.
MDA levels were significantly higher in 99mTc-DMSA, 99mTc-MAG-3 
administered patients and total renal scintigraphy performed 
patient groups than the control group (p < 0.05). In addition, 
researchers stated that gamma radiation at clinically used dos-
es stimulates lipid peroxidation in human red cells [25]. ROS 
can initiate lipid peroxidation that is a chain reaction. Once lipid 
peroxidation is initiated, it results in the oxidative deterioration of 
polyunsaturated fatty acids and caused increased MDA levels [25]. 
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Furthermore, these results are in agreement with previous animal 
and human studies that demonstrated 99mTc-DTPA [20], 99mTc-MIBI 
[21] and microwave radiation [24] caused increased MDA levels. 
However, 99mTc pertechnetate caused decreased MDA levels in 
patients [26].
The results acquired in this research study confirms that ionizing 
radiation causes different changes at antioxidant enzyme levels. 
However, to the best of our knowledge there is no similar clinical 
study reports on the effect of ionizing radiation due to 99mTc-MIBI 
and 99mTc-MDP on nitrosative stress parameters (NO, 3-NTx) in 
human. Therefore, we could not compare our results with those of 
others. We only could compare our findings on nitrosative stress pa-
rameters only with our previous reports that were performed in 
different patients groups and with different radiopharmaceutical 
agents including 99mTc pertechnetate and 99mTc-MDP. 
NO levels were higher in the first patient group than the con-
trol group but it was not statistically significant (p > 0.05). 3-NTx 
levels were statistically significantly higher in the first patient group 
than the control group (p < 0.05).
NO, 3-NTx levels were higher in 99mTc-DMSA, 99mTc-MAG-3 ad-
ministered patients and total renal scintigraphy performed patient 
groups than tthe control group (p < 0.05).
We reported that NO and 3-NTx levels were increased in pa-
tients who have performed thyroid scintigraphy with 99mTc pertech-
netate and bone scintigraphy with 99mTc-MDP [17–18]. 
Figure 4. The activities of nitric oxide (NO); A. and nitrotyrosine 
(3-NTx); B. Levels as nitrosative stress biomarkers in second patient 
group and control group
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Figure 5. The activities of catalase (CAT); A. Superoxide dismutase 
(SOD); B. and malondialdehyde (MDA); C. Levels as oxidative stress 
biomarkers in third patient group and control group
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Nitric oxide (NO.) has one unpaired electron, hence it is ac-
cepted as a radical. NO. is produced in biological systems via 
specific nitric oxide synthases (NOSs). NO. plays an important role in 
various physiological conditions, such as neurotransmission, blood 
pressure regulation, defence mechanisms, smooth muscle relaxa-
tion and immune regulation. NO. chemically reacts with oxygen and 
water, as a result of that nitrate and nitrite anions are produced. 
NO. also reacts with superoxide anion and peroxynitrite (ONOO–) 
is produced. Reactivity of ONOO– is higher than NO.. ONOO– re-
acts with proteins, thus nitrotyrosine (3-NTx) is produced. 3-NTx 
is a characteristic marker of nitrosative stress. It is known that NO 
and 3-NTx levels are increased in various diseases such as skin 
cancers, systemic lupus erythematosus, and atopic dermatitis [27]. 
NO, is produced by endothelial and endocardial tissue, 
has a significant effect on myocard and its vascular function. 
Coronary heart disease (CHD) is a chronic inflammatory pro-
cess that becomes against vascular damage. Endothelial dis-
function causes CHD when endothelial cells cannot perform their 
functions including NO production. Furthermore, free oxygen 
radicals negatively effect NO production in MPS performed pa-
tients. Because of that, NO levels might not statistically increased 
in 99mTc-MIBI administered group in this study [28–30]. 
This research, however, is subject to some limitations. There 
were an insufficient number of patients and number of blood 
samples. The samples were only taken after radiopharmaceutical 
Figure 6. The activities of nitric oxide (NO); A. and nitrotyrosine (3-
NTx); B. Levels as nitrosative stress biomarkers in third patient group 
and control group
 
A 
 
B 
 
 
 
 
 
 
 
0
5
10
15
20
25
MAG-3 Control
NO 
0
1
2
3
4
5
6
MAG-3 Control
3-NTx 
Figure 7. The activities of catalase (CAT); A. Superoxide dismutase 
(SOD); B. and malondialdehyde (MDA); C. Levels as oxidative stress 
biomarkers in total renal scintigraphy performed  patient groups and 
control group
A 
 
B 
 
C 
 
0
5
10
15
20
Patients Control
CAT 
0
500
1000
1500
2000
2500
3000
3500
4000
Patients Control
SOD 
0
1
2
3
4
5
6
Patients Control
MDA 
89www.journals.viamedica.pl/nuclear_medicine_review
Ebru Salmanoglu, Ergul Belge Kurutas, Scintigraphy and oxidative/nitrosative stress
Original
Figure 8. The activities of nitric oxide (NO); A. and nitrotyrosine 
(3-NTx); B. Levels as nitrosative stress biomarkers in total renal 
scintigraphy performed patient groups  and control group
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administration. If the samples were taken before agent injection, it 
would be more clear to understand whether oxidative/nitrosative 
stress parameters were changed due to ionizing radiation or cardiac 
and renal disease of patients.
Conclusion
Taking the results of current study into consideration, we able 
to show alterations in oxidative/nitrosative stress parameters due 
to ionizing radiation. Although, the effects of scintigraphic imaging 
methods on free radicals are yet to be completely elucidated, shortly 
after ionizing radiation exposure, cellular protective pathways are 
activated to overcome harmful effects of ROS/RNS production due 
to ionizing radiation. In the literature there are no studies evaluating 
nitrosative stress levels in patients who undergone MPS, dynamic 
renal scintigraphy and renal cortical scintigraphy. This present 
study demonstrated that ionizing radiation due to MPS, dynamic 
renal scintigraphy and renal cortical scintigraphy applications have 
different effects on antioxidant enzyme levels. All of these meth-
ods increased MDA levels and nitrosative stress parameters. Our 
study will contribute current literature understanding radiobiological 
effects of scintigraphic imaging agents on especially nitrosative 
stress parameters. However, further studies in a larger number of 
the population are needed to fully understand this topic.
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